Sumitomo Pharma
Healthcare & Life Sci
Company overview
Sumitomo Pharma is a Japanese multinational pharmaceutical company. It specializes in oncology, psychiatry, neurology, women's health and urological diseases. Its products include Latuda, an antipsychotic medication, and Orgovyx, a drug for treating prostate cancer. The company develops and sells medicines across these therapeutic areas.
The company traces its roots to Dainippon Pharmaceuticals, established in 1885, and is headquartered in Chuo-ku, Osaka, Japan. Sumitomo Chemical has held 51% or more ownership since a 2005 merger. Sumitomo Pharma reported revenue of $4.18 billion in fiscal year 2022, giving a sense of its scale within a much larger chemical conglomerate. Historically, the median salary is ~$133,750. Sumitomo Pharma is an H-1B sponsor.
- Industry
- Healthcare & Life Sci
- Headquarters
- Osaka, Japan